comparemela.com
Latest Breaking News On - Ms comprehensive care center - Page 1 : comparemela.com
Ublituximab Bests Teriflunomide for MS in Two Phase 3 Trials
Ublituximab is superior to teriflunomide in suppressing multiple sclerosis relapses and lesions on MRI, suggest findings from the phase 3 ULTIMATE I and II trials.
Lawrence-steinman
Viela-bio
Genentech-roche
Patricia-coyle
Sanofi-genzyme
Glaxosmithkline
Stanford-calif-university
Alkermes
Ms-comprehensive-care-center
Bristol-myers-squibb
Stony-brookny-neurosciences-institute
Novartis
vimarsana © 2020. All Rights Reserved.